Moderna’s next trick: a three-in-one vaccine for respiratory diseases

Moderna Inc., hoping to avoid gaining a reputation as a one-hit wonder over its Covid-19 vaccine, is bringing attention to its next major product: a sole vaccine for Covid-19 and two other viruses.